Your browser doesn't support javascript.
The Carbon Costs of In-Person Versus Virtual Medical Conferences for the Pharmaceutical Industry: Lessons from the Coronavirus Pandemic.
Gattrell, William T; Barraux, Aurélie; Comley, Sam; Whaley, Michael; Lander, Nicholas.
  • Gattrell WT; Ipsen, 102 Park Dr, Milton, Abingdon, OX14 4RY, UK. wgattrell@yahoo.co.uk.
  • Barraux A; Ipsen, Paris, France.
  • Comley S; Ipsen, Slough, UK.
  • Whaley M; Ipsen, Cambridge, MA, USA.
  • Lander N; N Lander Consulting, Melbourne, VIC, Australia.
Pharmaceut Med ; 36(2): 131-142, 2022 04.
Article in English | MEDLINE | ID: covidwho-1712377
ABSTRACT

BACKGROUND:

Many in-person congresses have shifted to a virtual format owing to coronavirus disease 2019 (COVID-19). We assessed carbon emissions savings associated with virtual attendance at international medical congresses for a mid-sized pharmaceutical company, to identify which aspects are driving the carbon cost.

METHODS:

We assessed carbon emissions that were the responsibility of company attendees (including their guests) for the most attended congresses by employees (American Society of Clinical Oncology [ASCO], European Neuroendocrine Tumor Society [ENETS], European Society for Medical Oncology [ESMO], World Congress for NeuroRehabilitation [WCNR]). For in-person estimates, we considered travel, accommodation and congress attendance; for online estimates, we considered office and internet-related energy use. Emissions were defined using recognised data sources.

RESULTS:

For 1723 anticipated in-person attendees, calculated total carbon emissions were 3,262,574 kgCO2e (mean per in-person company attendee, 1894 kgCO2e ASCO, 4172; ESMO, 1479; WCNR, 1153; ENETS, 1009). For context, the average UK resident's annual carbon footprint is 5600 kgCO2e. Travel accounted for 91-96% of total emissions, mainly through long distance and business-class air travel. Calculated total carbon emissions associated with 1839 virtual attendees were 19,095 kgCO2e (mean per virtual company attendee, 10.4 kgCO2e; equivalent to approximately 0.3-1.1% of in-person attendance emissions across all four congresses assessed).

CONCLUSION:

Carbon emissions associated with virtual attendance were two orders of magnitude lower than for in-person attendance, and therefore the benefits of in-person attendance at medical congresses must be balanced against the carbon cost. Due diligence around who should attend and how they should travel to face-to-face meetings, and consideration of hybrid and domestic satellite options could be part of a balanced solution to reducing carbon emissions.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Air Travel / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Pharmaceut Med Year: 2022 Document Type: Article Affiliation country: S40290-022-00421-3

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Air Travel / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Pharmaceut Med Year: 2022 Document Type: Article Affiliation country: S40290-022-00421-3